Biotechnology in East Anglia

Taylor Wessing LLP

Taylor Wessing LLP has a deep bench of life sciences and technology specialists with extensive experience in advising some of the world's leading pharmaceutical companies. It provides market-leading advice on complex global licensing and collaboration deals, contract disputes and venture capital financing. Through co-head of international life sciences and healthcare Tim Worden, who works closely with UK head of life sciences Malcolm Bates, the firm also provides regulatory advice to the leading names in the sector. Senior associates Tasmina Goraya and Talitha Shkopiak are recommended as rising stars in the sector.

Practice head(s):

Malcolm Bates; Tim Worden

Other key lawyers:

David Mardle; Adrian Rainey; Talitha Shkopiak; Tasmina Goraya; Georgia Powell; Colin McCall; Samantha Deacon


“Malcolm Bates and his team consistently demonstrate their expertise and experience in the biotechnology sector.”

“Both Talitha Shkopiak and Malcolm Bates are very responsive and show great commercial understanding of the pharmaceutical industry.”

Key clients

TxCell S.A. / Sangamo Therapeutics

Oxford BioMedica plc

Artios Pharma Ltd.


MiNA Therapeutics

Avacta plc


Forbion Capital Partners


Work highlights

  • We advised TxCell, a listed French cell therapy company, on an in-licence from the University of British Columbia under intellectual property rights relating to TxCell’s lead cellular immunotherapy product for chronic rejection after organ transplantation.
  • Advised longstanding client Oxford BioMedica plc on an exclusive worldwide licence of its gene therapy treatment for Parkinson’s Disease.
  • Advised Oxford BioMedica plc on a research collaboration and licence with Bioverativ Inc. for the development and manufacturing of lentiviral vectors to treat haemophilia.
  • We represented Apotex Inc on the sale of its European subsidiaries in Belgium, Poland, the Netherlands, the Czech Republic and Spain, to Aurobindo.
  • We have advised Plethora Solutions Limited on a second licence agreement (following the grant of rights in Europe and certain other countries in 2014) granting the rights to commercialise PSD502™, Plethora’s approved novel anaesthetic drug.

Mills & Reeve LLP

Mills & Reeve LLP operates a full-service multi-disciplinary practice for life sciences companies. Its clients include global organisations as well as small and mid-sized biotech companies, universities and research institutes. Led by James Fry, the practice draws on the experience of IP consultant Alasdair Poore and corporate finance partner Zickie Lim, as well as lawyers in the firm's employment, pensions, immigration and litigation groups.

Practice head(s):

James Fry

Other key lawyers:

Alasdair Poore; Zickie Lim

Key clients

ALK Abello


Alere / Abbott / Axis Diagnostics

Diurnal Group

Sphere Fluidics

Calypso Biotech

ECO Animal Health

Kidney Research UK

IQ Capital Funs


University of Exeter

Wellcome Sanger Institute

Atlantic Healthcare

British Association of Dermatologists

Francis Crick Institute

L. D. Collins & Co

MAP Biopharma

Aberystwyth University

Horizon Discovery

Work highlights

  • Advising this Danish global pharma group on UK product compliance issues generally, including e-commerce, privacy, advertising, branding and pharma/medical device regulation.
  • We have assisted this client generally on commercial and IP matters this year, and, in particular, on its suite of supply chain and market access agreements.
  • We advised this Cambridge based  life sciences business (formerly spun out of the University of Cambridge) on its £5m fundraising.
  • We assist the Alere Group, a global diagnostics corporation, on a range of commercial and HR matters.
  • Calypso is an early stage oncology therapeutic company and we have assisted on a range of CRO/pharmaceutical product development agreements and IP matters.

Penningtons Manches Cooper LLP

Biotechnology is a key industry sector across the national network of offices of Penningtons Manches Cooper LLP and the key lawyers in Cambridge advise start-ups and established life sciences companies on corporate, IP, IT, property and finance matters. Among its clients are numerous biotechnology, medical device, diagnostics and pharmaceutical companies, as well as research institutes. The firm, which climbs the ranking this year, has a dedicated IP, IT and commercial lawyer in senior associate Rachel Bradley and an experienced employment partner in Hilary Aldred.

Practice head(s):

Rachel Bradley

Other key lawyers:

Hilary Aldred; Sarah Coates

Key clients

Wren Therapeutics


Atopix Therapeutics

King’s Commercialisation Institute

Astex Therapeutics

Orca Pharmaceuticals




King’s Commercialisation Institute


Work highlights

  • We advised this client on an amendment to a clinical research agreement with a UK academic institution.
  • Acting for US-based Oppilan, a San Diego based drug discovery company on their various funding rounds and other UK corporate matters.
  • Acting for Wren on all of its UK legal advice, including commercial/IP matters, HR and employee options.
  • Negotiating a new lease for premises of Granta Park.
  • Represented a client in its Research and Option agreement with a large global pharmaceutical company.

Marks & Clerk Law

Niche intellectual property firm Marks & Clerk Law has a large client base in the life sciences sector and although the majority of work is done through the London office, associate Simon Portman in Cambridge is a notable commercial contract lawyer for technology companies and acts for numerous clients in the bioscience industry.